Literature DB >> 12058767

Procreative beneficence: why we should select the best children.

J Savulescu1.   

Abstract

Eugenic selection of embryos is now possible by employing in vitro fertilization (IVF) and preimplantation genetic diagnosis (PGD). While PGD is currently being employed for the purposes of detecting chromosomal abnormalities or inherited genetic abnormalities, it could in principle be used to test any genetic trait such as hair colour or eye colour. Genetic research is rapidly progressing into the genetic basis of complex traits like intelligence and a gene has been identified for criminal behaviour in one family. Once the decision to have IVF is made, PGD has few 'costs' to couples, and people would be more inclined to use it to select less serious medical traits, such as a lower risk of developing Alzheimer Disease, or even for non-medical traits. PGD has already been used to select embryos of a desired gender in the absence of any history of sex-linked genetic disease. I will argue that: (1) some non-disease genes affect the likelihood of us leading the best life; (2) we have a reason to use information which is available about such genes in our reproductive decision-making; (3) couples should select embryos or fetuses which are most likely to have the best life, based on available genetic information, including information about non-disease genes. I will also argue that we should allow selection for non-disease genes even if this maintains or increases social inequality. I will focus on genes for intelligence and sex selection. I will defend a principle which I call Procreative Beneficence: couples (or single reproducers) should select the child, of the possible children they could have, who is expected to have the best life, or at least as good a life as the others, based on the relevant, available information.

Entities:  

Keywords:  Analytical Approach; Genetics and Reproduction

Mesh:

Year:  2001        PMID: 12058767     DOI: 10.1111/1467-8519.00251

Source DB:  PubMed          Journal:  Bioethics        ISSN: 0269-9702            Impact factor:   1.898


  72 in total

Review 1.  Human Germline Genome Editing.

Authors:  Kelly E Ormond; Douglas P Mortlock; Derek T Scholes; Yvonne Bombard; Lawrence C Brody; W Andrew Faucett; Nanibaa' A Garrison; Laura Hercher; Rosario Isasi; Anna Middleton; Kiran Musunuru; Daniel Shriner; Alice Virani; Caroline E Young
Journal:  Am J Hum Genet       Date:  2017-08-03       Impact factor: 11.025

Review 2.  Education and debate: Deaf lesbians, "designer disability," and the future of medicine.

Authors:  Julian Savulescu
Journal:  BMJ       Date:  2002-10-05

3.  A rational cure for prereproductive stress syndrome.

Authors:  M Häyry
Journal:  J Med Ethics       Date:  2004-08       Impact factor: 2.903

4.  The myth of genetic enhancement.

Authors:  Philip M Rosoff
Journal:  Theor Med Bioeth       Date:  2012-06

5.  A new era in prenatal testing: are we prepared?

Authors:  Dagmar Schmitz
Journal:  Med Health Care Philos       Date:  2013-08

Review 6.  In search of biomarkers for autism: scientific, social and ethical challenges.

Authors:  Pat Walsh; Mayada Elsabbagh; Patrick Bolton; Ilina Singh
Journal:  Nat Rev Neurosci       Date:  2011-09-20       Impact factor: 34.870

7.  Screening Human Embryos for Polygenic Traits Has Limited Utility.

Authors:  Ehud Karavani; Or Zuk; Danny Zeevi; Nir Barzilai; Nikos C Stefanis; Alex Hatzimanolis; Nikolaos Smyrnis; Dimitrios Avramopoulos; Leonid Kruglyak; Gil Atzmon; Max Lam; Todd Lencz; Shai Carmi
Journal:  Cell       Date:  2019-11-21       Impact factor: 41.582

8.  Constructing critical bioethics by deconstructing culture/nature dualism.

Authors:  Richard Twine
Journal:  Med Health Care Philos       Date:  2005

9.  Epistemic Virtue, Prospective Parents and Disability Abortion.

Authors:  James B Gould
Journal:  J Bioeth Inq       Date:  2019-08-01       Impact factor: 1.352

10.  The best possible child.

Authors:  Michael Parker
Journal:  J Med Ethics       Date:  2007-05       Impact factor: 2.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.